A new study published in the Journal of Urology Open Plus reveals that 7 saw palmetto products met the identity and potency standards to effectively address urinary tract symptoms associated with an enlarged prostate.
Arecor to retain Inhibrx royalties in wake of Sanofi acquisition
The company that developed the technology behind Sanofi’s purchase of Inhibrx said that royalty obligations won’t change with the acquisition. Arecor, a Cambridge, UK startup,
January 25, 2024